Your browser doesn't support javascript.
loading
Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome.
Hu, Tengpeng; Buus, Terkild Brink; Krejsgaard, Thorbjørn; Nansen, Anneline; Lundholt, Betina Kerstin; Spee, Pieter; Fredholm, Simon; Petersen, David Leander; Blümel, Edda; Gluud, Maria; Monteiro, Madalena N; Willerslev-Olsen, Andreas; Andersen, Mads Hald; Straten, Per Thor; Met, Özcan; Stolearenco, Veronica; Fogh, Hanne; Gniadecki, Robert; Nastasi, Claudia; Litman, Thomas; Woetmann, Anders; Gjerdrum, Lise Mette Rahbek; Ødum, Niels.
Afiliação
  • Hu T; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Buus TB; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Krejsgaard T; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Nansen A; Department of Molecular Pharmacology, Zealand Pharma A/S, Glostrup, Denmark.
  • Lundholt BK; Department of Molecular Pharmacology, Zealand Pharma A/S, Glostrup, Denmark.
  • Spee P; PS Pharmaconsult, Allerød, Denmark.
  • Fredholm S; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Petersen DL; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Blümel E; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Gluud M; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Monteiro MN; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Willerslev-Olsen A; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Andersen MH; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Straten PT; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital at Herlev, Copenhagen, Denmark.
  • Met Ö; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Stolearenco V; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital at Herlev, Copenhagen, Denmark.
  • Fogh H; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Gniadecki R; Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital at Herlev, Copenhagen, Denmark.
  • Nastasi C; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Litman T; Department of Dermatology, Copenhagen University Hospital at Bispebjerg, Copenhagen, Denmark.
  • Woetmann A; Department of Dermatology, Copenhagen University Hospital at Bispebjerg, Copenhagen, Denmark.
  • Gjerdrum LMR; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Ødum N; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Oncotarget ; 10(47): 4894-4906, 2019 Aug 06.
Article em En | MEDLINE | ID: mdl-31448055

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article